quinoline has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahori, A; Fujiishi, Y; Fukumuro, M; Hayashi, M; Kawasako, K; Kougo, Y; Masumori, S; Nagai, M; Narumi, K; Natsume, M; Oba, M; Ohyama, W; Okada, E; Takami, S; Tanaka, J; Ueda, M; Uno, F; Wako, Y | 1 |
| Cui, L; Futakuchi, M; Hasegawa, R; Ito, N; Ogiso, T; Shirai, T; Yamamoto, A | 1 |
2 other study(ies) available for quinoline and Body Weight
| Article | Year |
|---|---|
Repeated-dose liver and gastrointestinal tract micronucleus assays for quinoline in rats.
Topics: Administration, Oral; Animals; Body Weight; Bone Marrow; Carcinogens; Chromosome Aberrations; Cooperative Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastrointestinal Tract; Hepatocytes; Humans; Japan; Liver; Male; Micronucleus Tests; Organ Specificity; Quinolines; Rats; Rats, Sprague-Dawley; Reticulocytes; Societies, Pharmaceutical | 2015 |
Low susceptibility of the spontaneously hypertensive rat (SHR) to quinoline-induction of hepatic hemangioendothelial sarcomas.
Topics: Animals; Body Weight; Captan; Carcinogens; Cocarcinogenesis; Cyclohexenes; Disease Susceptibility; Fungicides, Industrial; Hemangioendothelioma; Hypertension; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |